What is Disc Medicine's long-term debt?

Disc Medicine (IRON) reported long-term debt of $29.37M in Q1 2026.

How has Disc Medicine's long-term debt changed year-over-year?

Disc Medicine's long-term debt increased by 2.9% year-over-year, from $28.53M to $29.37M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Disc Medicine IRON Long-Term Debt

Long-Term Debt at other companies

Bristol-Myers SquibbBMY

$42.15B-8.7%

Beam TherapeuticsBEAM

$100.19M—

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Operating income-$69.5M-74.0%

Net income-$63.5M-86.3%

EPS (diluted)-$1.65-61.8%

Balance sheet

See full

Cash & equivalents$88.9M-27.5%

Total debt$31.1M+1.4%

Total equity$688.4M+4.3%

Total assets$750.2M+5.8%

Cash flow

See full

Operating cash flow-$62.2M-50.4%

CapEx--100%

Free cash flow-$62.2M-47.4%

Valuation

See full

Market cap$2.69B+42.2%

Enterprise value$2.63B+46.7%

Returns & leverage

See full

Return on equity-35.8%+41.3pp

Debt / equity0×0.0×

Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebt.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Disc Medicine's long-term debt?: Disc Medicine (IRON) reported long-term debt of $29.37M in Q1 2026.
How has Disc Medicine's long-term debt changed year-over-year?: Disc Medicine's long-term debt increased by 2.9% year-over-year, from $28.53M to $29.37M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.